Short answer · Medically reviewed summary · Last updated: 2026-05-08
Yes, Primary Hyperoxaluria is a strictly hereditary genetic condition that is passed down from parents to their children. It follows an autosomal recessive inheritance pattern, meaning both biological parents must typically carry a disease-causing variant in the same gene for their child to be affected. Is Primary Hyperoxaluria hereditary and how is it passed on? Primary Hyperoxaluria is a genetic metabolic disorder caused by mutations in specific genes (most commonly AGXT, GRHPR, or HOGA1).
Yes, Primary Hyperoxaluria is a strictly hereditary genetic condition that is passed down from parents to their children. It follows an autosomal recessive inheritance pattern, meaning both biological parents must typically carry a disease-causing variant in the same gene for their child to be affected.
Primary Hyperoxaluria is a genetic metabolic disorder caused by mutations in specific genes (most commonly AGXT, GRHPR, or HOGA1). Because it is autosomal recessive, an affected individual has inherited two copies of the mutated gene—one from each parent. Parents of an affected child are typically "obligate carriers," meaning they each have one mutated gene and one normal gene, usually showing no symptoms of Primary Hyperoxaluria themselves.
When both parents are carriers, the risks for each pregnancy are as follows:
Genetic testing is the gold standard for confirming a diagnosis of Primary Hyperoxaluria. It is highly recommended to identify the specific gene involved, as this dictates the clinical management and potential responsiveness to treatments like Vitamin B6. Genetic counseling is essential for families to understand these risks, discuss the availability of prenatal diagnosis, and explore options such as preimplantation genetic testing (PGT) during IVF.
De novo (spontaneous) mutations are extremely rare in Primary Hyperoxaluria. The vast majority of cases are inherited from carrier parents. Because the condition is recessive, the recurrence risk for future pregnancies in affected families remains consistently at 25%.
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.